Glyphic Biotechnologies
Glyphic2

We sequence proteins.

Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics.

While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.

At Glyphic Biotechnologies, we are creating the protein revolution for which scientists and researchers have been waiting. Our team is comprised of talented scientists, engineers, and people who care about changing the underlying engines of biomedical discovery.

Joshua Yang (he/him)

Co-Founder and CEO

Daniel Estandian (he/him)

Co-Founder and CTO

Craig Asher (he/him)

Board Member

News & Updates

Backed by the Best

We're proudly backed by some of the leading biotech investors who believe in the revolutionary potential of our protein sequencing technology.

Let's Chat. Partner. Collaborate. Team Up. Discuss. Talk. Co-Develop.

Let's build something great and change the future of proteomics together.

Send us a message!

Subscribe to our updates!

Enter your email address to subscribe to Glyphic Biotechnologies and receive notifications of our updates by email.

Thanks for the Support